Genetix' six-month sales soar 73%

New Milton, UK-based Genetix, a cell biology and health technology group, says that for the six months ended June 30, sales increased 73% to L10.4 million ($20.9 million), resulting in adjusted operating profit of L1.0 million, up 59%. The firm explained that strong growth of its new cell biology products, up 69% to L2.6 million, had driven its half-year performance.

Genetix noted that the results included a contribution from USA-based Applied Imaging Corp, the acquisition of which was completed late last year (Marketletters passim), and added that corporate integration was progressing well.

Despite the largely positive news, pre-tax profits for the period were down slightly, falling 10.3% to L1.1 million from the comparable period last year. The firm said, however, that it was confident that its full-year results would be in line with management expectations.